Fig. 3From: Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trialsHypoglycemia in responders and nonresponders to insulin glargine 100 Units/mL at 24 weeks. Data are incidence (a) and 1-year event rates (b)Back to article page
